191 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:58
202 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:28
220 0 Fei Yifei 2016-8-22 publish Last reply on 2016-8-22 09:23
288 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 12:03
223 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:41
247 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:14
233 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 10:42
304 0 Fei Yifei 2016-8-20 publish Last reply on 2016-8-20 21:47
224 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 20:23
272 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 19:57
281 0 Wuhan Medical 2016-8-20 publish Last reply on 2016-8-20 15:40
193 0 special characteristics 2016-8-20 publish Last reply on 2016-8-20 09:32
196 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 16:36
223 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 14:56
231 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 11:52
222 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 10:29
239 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 09:23
270 0 special characteristics 2016-8-19 publish Last reply on 2016-8-19 09:03
212 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 19:22
189 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 17:20
223 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 16:14
245 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 13:00
231 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 11:19
237 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 11:17
245 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 10:49
Point rules of this version Post Rebroadcast to the audience